n (%) or median (IQR) | Missing values (%) | HR | ||
HbA1c ≥48 mmol/mol (6.5%) | Glucose-lowering treatment initiation | |||
Total | 20 806 (100.0) | |||
Sex | 0 (0.0) | |||
Female | 10 792 (51.9) | 0.67 (0.62; 0.73) | 0.68 (0.61; 0.76) | |
Male | 10 014 (48.1) | Ref | Ref | |
Age (years) | 69.6 (61.0–77.1) | 0 (0.0) | 0.99 (0.98; 0.99) | 0.97 (0.96; 0.97) |
Body mass index (kg/m2) | 26.7 (24.1–29.8) | 986 (4.7) | 1.05 (1.04; 1.06) | 1.07 (1.06; 1.08) |
Value of pre-diabetes-defining HbA1c measurement (mmol/mol) | 43.0 (42.0–44.0) | 0 (0.0) | 1.69 (1.65; 1.73) | 1.68 (1.63; 1.74) |
Value of pre-diabetes-defining HbA1c measurement (mmol/mol) | 0 (0.0) | |||
42 | 9081 (43.6) | Ref | Ref | |
43 | 5061 (24.3) | 1.67 (1.47; 1.89) | 1.58 (1.32; 1.89) | |
44 | 3080 (14.8) | 2.74 (2.41; 3.12) | 2.89 (2.43; 3.44) | |
45 | 1794 (8.6) | 5.15 (4.53; 5.86) | 5.24 (4.39; 6.24) | |
46 | 1180 (5.7) | 7.93 (6.93; 9.07) | 8.04 (6.71; 9.62) | |
47 | 610 (2.9) | 13.69 (11.75; 15.94) | 12.48 (10.15; 15.34) |
The HR is adjusted for sex, age, index year, and region of residence.